Scout | Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)

This opportunity is no longer accepting applications.

grant

Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)

The CEBRA grant from the National Institute on Drug Abuse supports innovative research in substance use disorders. It targets high-risk, high-impact studies not covered by current projects, with the potential to transform the field. Research should develop groundbreaking techniques or test new hypotheses with little prior data, aiming to revolutionize addiction research and treatment approache…

Source

Agency: National Institutes of Health

Program: SBIR

Award

Award Ceiling: $150,000

Funding Amount: $150,000

Dates

Open for Submission: March 26, 2021

Opportunity Released: March 26, 2021

Submission Deadline: August 14, 2024

Application Window Closes: August 14, 2024

Keywords

CEBRA

NIDA

substance use disorders

SUD research

innovative research

addiction research

high-risk research

high-impact research

etiology

pathophysiology

prevention

treatment.

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers